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KIDNEY TRANSPLANTATION (KT) is sometimesthe only option for the treatment of patients with
chronic renal failure. In these circumstances, it is per-
formed in “very urgent” conditions in recipients, usually
with several risk factors for KT. These procedures are
associated with a lower degree of recipient/graft compati-
bility. To our knowledge, there are few studies published
about this circumstance.
PATIENTS AND METHODS
We performed a retrospective analysis of the kidney transplants
performed at our center under “very urgent” conditions.
RESULTS
Between 1983 and 2001, a total of 1108 KTs were per-
formed at our center. The overall patient and kidney graft
survivals were 96.1% and 88.4% at 1 year; 89.9% and 77.6%
at 5 years; 78.2% and 58.5% at 10 years, respectively. We
studied 19 patients (pts) who undervent “very urgent” KT
including 14 women (mean age  45.3  13.1 years at date
of transplantation). All grafts were from cadaveric donors,
four were second KTs, with a mean time of dialysis being
5.9  3.7 years. The reasons for including these pts in a
“very urgent” waiting list for KT included exhaustion of
vascular accesses and impossibility of peritoneal dialysis (15
pts); high sensitization with a panel reactive antigen (PRA)
80% (3 pts); and refusal of dialytic treatment (1 pt).
Excluding the hypersensitized patients, the mean time in
the waiting list under “very urgent” conditions was 52.0 
36.9 days. Associated co-morbidity factors were ischemic
heart disease 21%; cerebrovascular disease 5.2%; diabetes
21%; morbid obesity 21%. Seven pts had 1 HLA-A or -B
match; 2 pts had 2 HLA-A or -B match; 6 pts had 1
HLA-DR match. The PRA was higher than 30% in 52.6%
of the pts, and in 20% of these the PRA was 80%. Seven
pts (36.8%) had multiple blood transfusions. The immuno-
suppressive protocol was double (Cyclosporine [CyA];
prednisone), or triple (CyA, prednisone, azathioprine/
MMF) immunosuppression plus ATG in 63% of the pts,
triple immunosuppression with anti-CD25 in 15%; and
double or triple without antilymphocyte antibodies in 21%.
In addition, 63.2% had delayed graft function; two-thirds
due to acute tubular necrosis, one-third due to vascular
causes.
Acute rejection episodes were seen in 36.8% of pts,
leading to transplantectomy in 15.8%. Nine pts (47.4%)
died, four with a functioning kidney. In another 4 pts the
death was related to the KT. Causes of death were cardio-
vascular in 4 pts; hemorrhagic shock, 2 pts; sepsis, 1 pt;
calciphylaxis, 1 pt; and hypercalemia, 1 pt.
Excluding graft loss due to the death of the recipient (4
pts), 9 other grafts were lost due to immediate vascular or
immunologic causes, 21%; cardiovascular, 10.5%; late acute
rejection, 5.2%; chronic rejection, 5.2%; infection, 5.2%.
Six pts (31.6%) remain alive with a functioning graft. The
mean follow-up of these pts is 1000  129 days (2 to 4222
days).
DISCUSSION
Accepted criteria for “very urgent” KT for a dialysis patient
are intractable vascular access failure in the setting of failed
peritoneal dialysis or a highly sensitized patient. This type
of transplantation is associated with a higher risk of rejec-
tion and graft loss, particularly among the group of highly
sensitized patients. In a report from NEOB, the 1-year graft
survival was 85% for patients with a PRA between 0% and
49%, and 76% for patients with PRA greater then 90%.1
Approaches to treating these patients, including delivery of
more aggressive immunosuppressive therapy by administra-
tion of ATG, have offered substantial benefit.2 Patients with
exhaustion of vascular accesses for dialysis usually have
associated co-morbidity problems and a higher risk of
cardiovascular and thrombotic events, sometimes due to the
presence of a hypercoagulable state.
Finally, “very urgent” kidney transplantation is associ-
ated with high morbidity and mortality rates that are,
acceptable only in the absence of other treatment options.
Inclusion in the “very urgent” waiting list must obey very
narrow criteria and judicious selection.
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